All News Stories

Extensive and current diabetes news articles, including diabetic drug recalls and more.

New Metformin Could Help 40-percent of Diabetes Patients That Currently Can’t Take Metformin

New metformin treatment option for the 40 percent of diabetes patients that currently can't take this first-line drug of choice. Although metformin was introduced as...
UBCO researcher Jonathan Little

New Drink May Help Control Blood Sugar in Type 2 Diabetics

Ketone drinks may control glucose in type 2 diabetics by mimicking some aspects of a ketogenic diet. This offers another possible strategy in helping to manage Type 2 diabetes.
Why Some People Have Diabetes Remission and Other Don't

Type 2 Diabetes Trial: 46% Achieve Diabetes Remission Within 1 Year

After one year, 46% of the Type 2 Diabetic individuals in the intervention group recovered and maintained control over blood glucose concentrations.
Fasting-like Diet Reverses T1 and T2 Diabetes in Study

Periodic Fasting Diet May Reverse Type 1 and 2 Diabetes, Says USC-led study

A diet designed to imitate the effects of fasting appears to reverse diabetes for type 1 and type 2 diabetes by reprogramming cells, a...
ChromaDex Logo - Neuropathy Pain Relief

Nicotinamide Riboside Effective in Relieving Peripheral Neuropathy Induced by a Common Anticancer Agent

Findings of a recent study published in PAIN demonstrated what may lead to reductions in the neuropathic pain experienced by millions of patients suffering...
Baking Soda and Diabetic Ketoacidosis

Baking Soda May Prevent Fatal Infections in Diabetic Ketoacidosis

A recent study has found that a simple treatment of baking soda could prevent the spread of mucormycosis in patients with Diabetic Ketoacidosis. Patients with...
Diet to Reverse Type 2 Diabetes

Yale Researchers Uncover Diet to Reverse Type 2 Diabetes

Researchers, led by a Yale team, observed positive effects in as few as 3 days from a diet that can reverse type 2 diabetes and other health conditions.
Novo Nordisk NovoPen Recall

Novo Nordisk Recall: Novopen Echo Insulin Delivery Devices

Novo Nordisk is recalling certain Novopen Echo Insulin Delivery Devices due to potential health risks, including high blood sugar levels.

Drug Recall: Ranitidine Tablets, 150 mg and 300 mg Recalled Nationwide

Glenmark Pharmaceutical Inc., USA (“Glenmark”) announced on 12/19 the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to...
BASAGLAR - Insulin Discounted by Lilly for Diabetes

New Program will Provide Insulin at Discounted Prices

Certain people who use insulin to manage their diabetes may benefit from a 40-percent discount thanks to a new partnership, which would start on...
Verapamil for TYpe 1 Diabetes

Common Blood Pressure Medicine an Effective Type 1 Diabetes Therapy, Clinical Trial Reveals

Safe and effective therapy discovered to reduce insulin requirements and hypoglycemic episodes in certain Type 1 diabetics using a common blood pressure drug.
Vials of Tresiba

Tresiba Approved for Type 1 and Type 2 Diabetes

Tresiba has been approved by the FDA for both type 1 and type diabetes, marking the first new basal insulin molecule to be approved...

Diabetic Enteropathy Cause, Treatment and Possible Prevention Discovered

Diabetic enteropathy - with gastrointestinal symptoms like abdominal pain, bloating and nausea - may soon be preventable and treatable. Exciting news considering that it...
Obalon Balloon System for Weight Loss

Obalon Balloon System for Weight Loss, FDA Approves Marketing

The Obalon Balloon System, a weight-loss system that uses gastric balloons to occupy space in the stomach, has been approved by the FDA for...
Allulose - Rare Sugar Sweetener and Diabetes

Rare Sugar Sweeteners Helped Control Blood Glucose in Study

According to a recent study, low-calorie, natural rare sugars could help regulate glucose levels, which would make them a good option as a sweetener...
New Type 1 Diabetes Therapy Could Treat Humans and Dogs

New Therapy Offers Type 1 Diabetes Reversal within 24-hours in People & Dogs

The first minimally invasive therapy reverses Type 1 diabetes within 24 hours and maintains insulin independence created by Purdue Scientists.